BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

AMGEN USA, INC. — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

AMGEN USA, INC.

via AKIN GUMP STRAUSS HAUER & FELD

1st Quarter (Jan 1 - Mar 31) · 2026Posted Apr 20, 2026Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: AMGEN USA, INC.
Description: Biotechnology healthcare products.
Location: District of Columbia · United States of America

Registrant

Firm: AKIN GUMP STRAUSS HAUER & FELD
Description: Law firm
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Taxation/Internal Revenue Code
Issues related to international tax.
LobbyistsJEFF MCMILLEN · ZACHARY RUDISILL
TargetedSENATE · HOUSE OF REPRESENTATIVES · Treasury, Dept of

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.